GW-274150

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameGW-274150
Drug Alias Name274150GW-274150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase, inducible inhibitors
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsMigraine DisordersAsthmaArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSerbiaNetherlands +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsMigraine DisordersAsthmaArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A